Elite Pharmaceuticals, Inc.: 10-K filed 2019-06-21

Name: Elite Pharmaceuticals, Inc.: 10-K filed 2019-06-21
Creator: Elite Pharmaceuticals, Inc.

What Elite Pharmaceuticals, Inc. reported in its annual report filed 2019-06-21 (fiscal FY 2019): 47 published measures, 95 facts as tagged in accession 0001213900-19-011224.

This filing

Form: 10-K (annual report)
Filed: 2019-06-21
Fiscal period: fiscal FY 2019
Accession: 0001213900-19-011224 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Elite Pharmaceuticals, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2019-03-31	24,401,934	USD
At 2018-03-31	30,882,608	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2019-03-31	13,005,838	USD
At 2018-03-31	12,407,096	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2019-03-31	-2,507,864	USD
At 2018-03-31	4,571,552	USD
At 2017-03-31	25,664,037	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2019-03-31	2,277,643	USD
At 2018-03-31	7,179,237	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-9,279,321	USD	365
2017-04-01 to 2018-03-31	-3,673,172	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-6,792,760	USD	365
2017-04-01 to 2018-03-31	-4,809,191	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	7,568,508	USD	365
2017-04-01 to 2018-03-31	7,458,711	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	1,566,855	USD	365
2017-04-01 to 2018-03-31	1,671,067	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	330,870	USD	365
2017-04-01 to 2018-03-31	-274,847	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2019-03-31	-151,806,059	USD
At 2018-03-31	-142,526,738	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	814,172,891	shares	365
2017-04-01 to 2018-03-31	796,069,419	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	816,312,992	shares	365
2017-04-01 to 2018-03-31	798,169,419	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-0.01	USD/shares	365
2017-04-01 to 2018-03-31	0	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-0.01	USD/shares	365
2017-04-01 to 2018-03-31	-0.01	USD/shares	365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-676,016	USD	365
2017-04-01 to 2018-03-31	-1,045,829	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2019-03-31	8,443,849	USD
At 2018-03-31	8,993,708	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-9,158,700	USD	365
2017-04-01 to 2018-03-31	-9,051,279	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2019-03-31	8,856,542	USD
At 2018-03-31	13,702,401	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	369,173	USD	365
2017-04-01 to 2018-03-31	335,498	USD	365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2019-03-31	6,906,132	USD
At 2018-03-31	5,114,704	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2019-03-31	1,375,347	USD
At 2018-03-31	1,658,137	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2019-03-31	1,321,805	USD
At 2018-03-31	675,879	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	12,026,230	USD	365
2017-04-01 to 2018-03-31	12,998,867	USD	365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2019-03-31	4,515,723	USD
At 2018-03-31	4,898,001	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	2,867,530	USD	365
2017-04-01 to 2018-03-31	3,947,588	USD	365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	4,700,978	USD	365
2017-04-01 to 2018-03-31	3,511,123	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	7,599,820	USD	365
2017-04-01 to 2018-03-31	9,621,365	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2019-03-31	824,846,559	shares
At 2018-03-31	802,526,761	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2019-03-31	2,675,768	USD
At 2018-03-31	7,570,803	USD
At 2017-03-31	10,983,774	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2019-03-31	18,095,567	USD
At 2018-03-31	17,402,687	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2019-03-31	9,651,718	USD
At 2018-03-31	8,408,979	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2019-03-31	6,634,035	USD
At 2018-03-31	7,713,001	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2019-03-31	467,508	USD
At 2018-03-31	473,498	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2019-03-31	46,402	USD
At 2018-03-31	41,144	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2019-03-31	3,713,601	USD
At 2018-03-31	1,788,571	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2019-03-31	741,371	USD
At 2018-03-31	949,284	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-9,955,337	USD	365
2017-04-01 to 2018-03-31	-4,719,001	USD	365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-9,279,321	USD	365
2017-04-01 to 2018-03-31	-3,673,172	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	3,083,546	USD	365
2017-04-01 to 2018-03-31	2,332,289	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	1,242,739	USD	365
2017-04-01 to 2018-03-31	982,227	USD	365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	1,256,917	USD	365
2017-04-01 to 2018-03-31	996,406	USD	365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-796,637	USD	365
2017-04-01 to 2018-03-31	4,332,278	USD	365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	226,455	USD	365
2017-04-01 to 2018-03-31	135,146	USD	365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2017-04-01 to 2018-03-31	5,500	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	2,092,265	USD	365
2017-04-01 to 2018-03-31	1,999,878	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	545,926	USD	365
2017-04-01 to 2018-03-31	-258,180	USD	365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-382,278	USD	365
2017-04-01 to 2018-03-31	-1,517,965	USD	365

Inspect the source

Entity: Elite Pharmaceuticals, Inc. / CIK 0001053369
Captured: 2026-09-20T05:17:33.154Z
SEC response SHA-256: b91e0331a01f96870ee44e841f605bd504e1bc784022b77f374cfe93dc363314

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001053369.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))